skip to main content
Idioma:
Refinado por: assunto: Cervical Cancer remover BMJ Open Access Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response
Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response
Material Type:
Artigo 		Adicionar ao Meu Espaço

Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response

Baettig, Florence ; Vlajnic, Tatjana ; Vetter, Marcus ; Glatz, Katharina ; Hench, Jürgen ; Frank, Stephan ; Bihl, Michel ; Lopez, Roberto ; Dobbie, Michael ; Heinzelmann-Schwarz, Viola ; Montavon, Céline

Journal for immunotherapy of cancer, 2019-10, Vol.7 (1), p.281-281, Article 281 [Periódico revisado por pares]

England: BMJ Publishing Group Ltd

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Data de Publicação 

De até
Refinar

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.